183 related articles for article (PubMed ID: 32287264)
1. Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.
Asio J; Watera C; Namuwenge N; Kirungi W; Musinguzi J; Mugagga K; Busobozi R; Tusiime BJ; Lutalo T; Mbidde EK; Kaleebu P;
PLoS One; 2020; 15(4):e0230451. PubMed ID: 32287264
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
Mutenda N; Bukowski A; Nitschke AM; Nakanyala T; Hamunime N; Mekonen T; Tjituka F; Mazibuko G; Mwinga S; Mabirizi D; Sagwa E; Indongo R; Dean N; Jordan MR; Hong SY
PLoS One; 2016; 11(12):e0166649. PubMed ID: 27906995
[TBL] [Abstract][Full Text] [Related]
3. HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.
Jonas A; Sumbi V; Mwinga S; DeKlerk M; Tjituka F; Penney S; Jordan MR; Desta T; Tang AM; Hong SY
PLoS One; 2014; 9(7):e100539. PubMed ID: 24988387
[TBL] [Abstract][Full Text] [Related]
4. Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.
Fokam J; Elat JB; Billong SC; Kembou E; Nkwescheu AS; Obam NM; Essiane A; Torimiro JN; Ekanmian GK; Ndjolo A; Shiro KS; Bissek AC
PLoS One; 2015; 10(6):e0129210. PubMed ID: 26083364
[TBL] [Abstract][Full Text] [Related]
5. Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania.
Juma JM; Tiberio JK; Abuya MI; Kilama BK; Somi GR; Sambu V; Banda R; Jullu BS; Ramadhani AA
BMC Infect Dis; 2014 Apr; 14():196. PubMed ID: 24725750
[TBL] [Abstract][Full Text] [Related]
6. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.
Do TN; Nguyen TM; Do MH; Masaya K; Dang TB; Pham TL; Yoshikawa K; Cao TT; Nguyen TT; Bui DD; Nguyen VK; Nguyen TL; Fujita M
Clin Infect Dis; 2012 May; 54 Suppl 4():S306-12. PubMed ID: 22544193
[TBL] [Abstract][Full Text] [Related]
7. HIV drug-resistance early-warning indicators and quality care in India: preliminary findings from a pilot study in Pune city.
Ghate M; Kadam D; Gaikwad N; Shankar S; Gurav S; Rahane G; Tanwar S; Rewari B; Gangakhedkar R
WHO South East Asia J Public Health; 2015; 4(2):123-129. PubMed ID: 28607310
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.
Dzangare J; Gonese E; Mugurungi O; Shamu T; Apollo T; Bennett DE; Kelley KF; Jordan MR; Chakanyuka C; Cham F; Banda RM
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S313-6. PubMed ID: 22544194
[TBL] [Abstract][Full Text] [Related]
9. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.
Fokam J; Billong SC; Bissek AC; Kembou E; Milenge P; Abessouguie I; Nkwescheu AS; Tsomo Z; Aghokeng AF; Ngute GD; Ndumbe PM; Colizzi V; Elat JB
BMC Public Health; 2013 Apr; 13():308. PubMed ID: 23565992
[TBL] [Abstract][Full Text] [Related]
10. Early warning indicators for HIV drug resistance in Cameroon during the year 2010.
Billong SC; Fokam J; Nkwescheu AS; Kembou E; Milenge P; Tsomo Z; Dion GN; Aghokeng AF; Mpoudi EN; Ndumbe PM; Colizzi V; Elat Nfetam JB
PLoS One; 2012; 7(5):e36777. PubMed ID: 22615810
[TBL] [Abstract][Full Text] [Related]
11. Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.
Fokam J; Nangmo A; Wandum C; Takou D; Santoro MM; Nlend AN; Ateba FN; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Lambo V; Fokunang C; Mbanya D; Colizzi V; Perno CF; Ndjolo A
AIDS Res Ther; 2020 May; 17(1):14. PubMed ID: 32398107
[TBL] [Abstract][Full Text] [Related]
12. Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand's Antiretroviral Treatment Program.
Lertpiriyasuwat C; Teeraratkul A; Suchonwanich Y; Chatharojwong N; Phokasawad K; Yuktanon P; Pattarapayoon N; Bhakeecheep S; Bertagnolio S; Roels TH; Thanprasertsuk S
J Med Assoc Thai; 2017 Sep; 100(9):944-952. PubMed ID: 29861515
[TBL] [Abstract][Full Text] [Related]
13. Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.
Hong SY; Jonas A; Dumeni E; Badi A; Pereko D; Blom A; Muthiani VS; Shiningavamwe AN; Mukamba J; Andemichael G; Barbara R; Bennett DE; Jordan MR
J Acquir Immune Defic Syndr; 2010 Dec; 55(4):27-31. PubMed ID: 20838224
[TBL] [Abstract][Full Text] [Related]
14. Early warning indicators of HIV drug resistance in the southern highlands region of Tanzania: Lessons from a cross-sectional surveillance study.
Khamadi SA; Mavere C; Bahemana E; Lwilla A; Mizinduko M; Bwigane S; Peter A; Makando J; Peter B; Agaba P; Shah N; Julu B; Ganesan K; Coakley P; Lee EH
PLOS Glob Public Health; 2023; 3(3):e0000929. PubMed ID: 36996096
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of implementing an integrated tool for improvement of treatment quality and early-warning indicators for HIV drug resistance: a pilot study of centres in India.
Rewari BB; Seguy NS; Tanwar SS; Chan PL; Purohit V; Harvey P; Yu D; Rathore AS
WHO South East Asia J Public Health; 2015; 4(2):184-188. PubMed ID: 28607317
[TBL] [Abstract][Full Text] [Related]
16. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
[TBL] [Abstract][Full Text] [Related]
17. HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.
Bennett DE; Jordan MR; Bertagnolio S; Hong SY; Ravasi G; McMahon JH; Saadani A; Kelley KF
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S280-9. PubMed ID: 22544188
[TBL] [Abstract][Full Text] [Related]
18. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
[TBL] [Abstract][Full Text] [Related]
19. "The number of clients is increasing but the supplies are reducing": provider strategies for responding to chronic antiretroviral (ARV) medicines stock-outs in resource-limited settings: a qualitative study from Uganda.
Zakumumpa H; Kiweewa FM; Khuluza F; Kitutu FE
BMC Health Serv Res; 2019 May; 19(1):312. PubMed ID: 31092245
[TBL] [Abstract][Full Text] [Related]
20. Results from implementing updated 2012 World Health Organization Guidance on early-warning indicators of HIV drug resistance in Zimbabwe.
Mungati M; Mhangara M; Dzangare J; Mugurungi O; Apollo T; Gonese E; Kilmarx PH; Chakanyuka-Musanhu CC; Shambira G; Tshimanga M
J Epidemiol Res; 2016; 2(2):85-91. PubMed ID: 29862318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
